{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:05:51Z","timestamp":1780581951431,"version":"3.54.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/501100007217","name":"Kaohsiung Municipal Kai-Syuan Psychiatric Hospital","doi-asserted-by":"publisher","award":["KSPH-2007-16"],"award-info":[{"award-number":["KSPH-2007-16"]}],"id":[{"id":"10.13039\/501100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007217","name":"Kaohsiung Municipal Kai-Syuan Psychiatric Hospital","doi-asserted-by":"publisher","award":["KSPH-2008-12"],"award-info":[{"award-number":["KSPH-2008-12"]}],"id":[{"id":"10.13039\/501100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-103-2314-B-280-001-MY3"],"award-info":[{"award-number":["MOST-103-2314-B-280-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/ijnp\/pyx114","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T14:38:53Z","timestamp":1512139133000},"page":"63-72","source":"Crossref","is-referenced-by-count":10,"title":["ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis"],"prefix":"10.1093","volume":"21","author":[{"given":"Ching-Hua","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"key\n\t\t\t\t20180201084709_CIT0001","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1176\/ajp.154.7.963","article-title":"Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study","volume":"154","author":"Amsterdam","year":"1997","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/002076402128783235","article-title":"Depression and quality of life: results of a follow-up study","volume":"48","author":"Angermeyer","year":"2002","journal-title":"Int J Soc Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0003","volume-title":"American Psychiatric Association: Structured Clinical Interview for DSM-IV","author":"APA","year":"1994"},{"key":"key\n\t\t\t\t20180201084709_CIT0004","volume-title":"The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association","author":"APA","year":"2001","edition":"2nd"},{"key":"key\n\t\t\t\t20180201084709_CIT0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4088\/JCP.v61n1003","article-title":"Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta\u2013analysis of the 20-mg\/day dose","volume":"61","author":"Beasley","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.31887\/DCNS.2005.7.3\/pberney","article-title":"Dose-response relationship of recent antidepressants in the short-term treatment of depression","volume":"7","author":"Berney","year":"2005","journal-title":"Dialogues Clin Neurosci"},{"key":"key\n\t\t\t\t20180201084709_CIT0007","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180201084709_CIT0008","doi-asserted-by":"crossref","first-page":"e4824","DOI":"10.1371\/journal.pone.0004824","article-title":"Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis","volume":"4","author":"Brunoni","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180201084709_CIT0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/YCT.0b013e3181a74368","article-title":"A survey of the practice of electroconvulsive therapy in Asia","volume":"26","author":"Chanpattana","year":"2010","journal-title":"J ECT"},{"key":"key\n\t\t\t\t20180201084709_CIT0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamapsychiatry.2013.286","article-title":"Incorporating multidimensional patient\u2013reported outcomes of symptom severity, functioning, and quality of life in the individual burden of illness index for depression to measure treatment impact and recovery in MDD","volume":"70","author":"Cohen","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0011","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1176\/ajp.150.5.720","article-title":"The enduring psychosocial consequences of mania and depression","volume":"150","author":"Coryell","year":"1993","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/JCP.0b013e318205e17b","article-title":"The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study","volume":"31","author":"Daly","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0013","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-5618.2001.030208.x","article-title":"ECT in bipolar and unipolar depression: differences in speed of response","volume":"3","author":"Daly","year":"2001","journal-title":"Bipolar Disord"},{"key":"key\n\t\t\t\t20180201084709_CIT0014","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YCT.0b013e3181f9789c","article-title":"Factors that influence electroconvulsive therapy referrals: a statewide survey of psychiatrists","volume":"27","author":"Dauenhauer","year":"2011","journal-title":"J ECT"},{"key":"key\n\t\t\t\t20180201084709_CIT0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ps.50.2.264","article-title":"A survey of psychiatrists\u2019 attitudes toward electroconvulsive therapy","volume":"50","author":"Finch","year":"1999","journal-title":"Psychiatr Serv"},{"key":"key\n\t\t\t\t20180201084709_CIT0016","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/acps.12251","article-title":"What was learned: studies by the consortium for research in ECT (CORE) 1997-2011","volume":"129","author":"Fink","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"key\n\t\t\t\t20180201084709_CIT0017","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1997.tb09926.x","article-title":"Electroconvulsive therapy vs paroxetine in treatment-resistant depression - a randomized study","volume":"96","author":"Folkerts","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"key\n\t\t\t\t20180201084709_CIT0018","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder third edition","volume":"167","author":"Gelenberg","year":"2010","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0019","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180201084709_CIT0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10673229.2011.614099","article-title":"Quality of life: the ultimate outcome measure of interventions in major depressive disorder","volume":"19","author":"Ishak","year":"2011","journal-title":"Harv Rev Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10488-011-0376-6","article-title":"Development and validation of the individual burden of illness index for major depressive disorder (IBI\u2013D)","volume":"40","author":"Ishak","year":"2013","journal-title":"Adm Policy Ment Health"},{"key":"key\n\t\t\t\t20180201084709_CIT0023","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511736216","volume-title":"Brain stimulation in psychiatry: ECT, DBS, TMS, and other modalities","author":"Kellner","year":"2012"},{"key":"key\n\t\t\t\t20180201084709_CIT0024","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1176\/appi.ajp.2012.12050648","article-title":"ECT in treatment-resistant depression","volume":"169","author":"Kellner","year":"2012","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00007691-198903000-00008","article-title":"Serum fluoxetine and norfluoxetine concentrations and antidepressant response","volume":"11","author":"Kelly","year":"1989","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t20180201084709_CIT0026","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","article-title":"Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database","volume":"22","author":"Khan","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.59.8.723","article-title":"Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo","volume":"59","author":"Kocsis","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0028","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/appi.ajp.2014.14101366","article-title":"Differential effectiveness of right unilateral vs bilateral electroconvulsive therapy in resistant bipolar depression","volume":"172","author":"Kotzalidis","year":"2015","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2011.03.046","article-title":"Clinical effectiveness: the importance of psychosocial functioning outcomes","volume":"132","author":"Lam","year":"2011","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180201084709_CIT0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1176\/appi.ps.55.12.1371","article-title":"Unemployment, job retention, and productivity loss among employees with depression","volume":"55","author":"Lerner","year":"2004","journal-title":"Psychiatr Serv"},{"key":"key\n\t\t\t\t20180201084709_CIT0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrics"},{"key":"key\n\t\t\t\t20180201084709_CIT0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/JCP.0b013e318210856f","article-title":"Early prediction of fluoxetine response for Han Chinese inpatients with major depressive disorder","volume":"31","author":"Lin","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.euroneuro.2015.12.019","article-title":"Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy","volume":"26","author":"Lin","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross\u2013sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"key\n\t\t\t\t20180201084709_CIT0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/JCP.0000000000000354","article-title":"Initial severity effects on residual symptoms in response and remission: A STAR*D study during and after failed citalopram treatment","volume":"35","author":"Madhoo","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0036","volume-title":"Clinical manual of electroconvulsive therapy, 1st ed","author":"Mankad","year":"2010"},{"key":"key\n\t\t\t\t20180201084709_CIT0037","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012373960-5.00335-X","volume-title":"The global burden of disease: 2004 update","author":"Mathers","year":"2008"},{"key":"key\n\t\t\t\t20180201084709_CIT0038","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/070674370705200908","article-title":"Psychosocial outcomes following electroconvulsive therapy in a community setting: retrospective chart review with 2-year follow-up","volume":"52","author":"Mathew","year":"2007","journal-title":"Can J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0039","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0327(00)00167-1","article-title":"Electroconvulsive therapy is associated with superior symptomatic and functional change in depressed patients after psychiatric hospitalization","volume":"63","author":"McCall","year":"2001","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180201084709_CIT0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.185.5.405","article-title":"Quality of life and function after electroconvulsive therapy","volume":"185","author":"McCall","year":"2004","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0041","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1192\/bjp.180.5.461","article-title":"The work and social adjustment scale: a simple measure of impairment in functioning","volume":"180","author":"Mundt","year":"2002","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0042","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/ajp.152.10.1500","article-title":"Early nonresponse to fluoxetine as a predictor of poor 8-week outcome","volume":"152","author":"Nierenberg","year":"1995","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0043","first-page":"208","article-title":"Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods","volume":"13","author":"Nobler","year":"1997","journal-title":"Convuls Ther"},{"key":"key\n\t\t\t\t20180201084709_CIT0044","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004850-199300810-00004","article-title":"Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine","volume":"8","author":"Norman","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.pra.0000361277.65468.ef","article-title":"Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT","volume":"15","author":"Payne","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"key\n\t\t\t\t20180201084709_CIT0046","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0047","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/YCT.0b013e3181719b23","article-title":"Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice","volume":"25","author":"Rasmussen","year":"2009","journal-title":"J ECT"},{"key":"key\n\t\t\t\t20180201084709_CIT0048","first-page":"24","article-title":"ECT and onset of action","volume":"62","author":"Roose","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0049","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","article-title":"Report by the ACNP Task Force on response and remission in major depressive disorder","volume":"31","author":"Rush","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180201084709_CIT0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","article-title":"Treatment\u2013resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy vs algorithm\u2013based pharmacological treatment","volume":"172","author":"Schoeyen","year":"2015","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0051","first-page":"8","article-title":"What constitutes an adequate antidepressant trial for fluoxetine","volume":"51","author":"Schweizer","year":"1990","journal-title":"J Clin psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0052","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0327(01)00352-4","article-title":"Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression","volume":"70","author":"Smith","year":"2002","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180201084709_CIT0053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180201084709_CIT0054","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study","volume":"68","author":"Souery","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0055","first-page":"216","article-title":"Fluoxetine: a five-year review","volume":"15","author":"Stokes","year":"1993","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180201084709_CIT0056","first-page":"17","article-title":"Treatment of severe depression","volume":"61","author":"Thase","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0057","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v67n0203","article-title":"Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report","volume":"67","author":"Trivedi","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180201084709_CIT0058","volume-title":"Applied longitudinal data analysis for epidemiology: a practical guide","author":"Twisk","year":"2003"},{"key":"key\n\t\t\t\t20180201084709_CIT0059","volume-title":"The ECT handbook, 3rd ed","author":"Waite","year":"2013"},{"key":"key\n\t\t\t\t20180201084709_CIT0060","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180201084709_CIT0061","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0277-9536(98)00009-4","article-title":"The world health organization quality of life assessment (WHOQOL): development and general psychometric properties","volume":"46","author":"WHO","year":"1998","journal-title":"Soc Sci Med"},{"key":"key\n\t\t\t\t20180201084709_CIT0062","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.nmd.0000258229.38212.6f","article-title":"Comparison of quality of life measures in a depressed population","volume":"195","author":"Wisniewski","year":"2007","journal-title":"J Nerv Ment Dis"},{"key":"key\n\t\t\t\t20180201084709_CIT0063","first-page":"97","article-title":"Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features","volume":"25","author":"Zaninotto","year":"2013","journal-title":"Ann Clin Psychiatry"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/21\/1\/63\/23741071\/pyx114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T20:07:04Z","timestamp":1660075624000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/21\/1\/63\/4708251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyx114","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,12,8]]}}}